Home Pharmacy
Health care payments in the United States are more regressive than previously thought

Wealthy Pay Most to Finance U.S. Health Care

However, share of income is greatest among households with lowest income
Potent prescription-strength topical corticosteroids without a prescription are readily available in many U.S. cities

Potent, Unregulated Steroid Creams Readily Available in U.S.

Potentially harmful, illegal topical steroids are being sold over the counter in foreign import stores
Older adult Medicare beneficiaries with untreated obstructive sleep apnea have increased health care utilization and costs

Health Care Utilization Up for Seniors With Untreated Apnea

Beneficiaries with OSA also demonstrate higher annual costs across all points of service
Treatment with intravenous vitamin C

High-Dose IV Vitamin C Does Not Speed Resolution of Septic Shock

Combination of vitamin C, hydrocortisone, thiamine not superior to usual care with hydrocortisone alone
Among nulliparous women with singleton pregnancies from low-income and middle-income countries

Low-Dose Aspirin Cuts Preterm Delivery in Nulliparous Women

Findings seen among women with singleton pregnancies in low-, middle-income countries
Many U.S. adults are misinformed about the influenza virus and the importance of flu vaccination

Many U.S. Adults Misinformed About the Flu, Vaccination

Only 49 percent of a national sample of U.S. adults reported having received the flu shot as of Dec. 2019
A nonprofit that develops and sells cheaper drugs will receive a $55 million investment from the Blue Cross Blue Shield Association and associated organizations to create cheaper versions of expensive generic drugs.

Major Insurers Offer $55 Million to Lower Generic Drug Costs

Nonprofit Civica Rx reached deal with Blue Cross Blue Shield and 18 of its member organizations
Compliance with the U.S. Food and Drug Administration Amendments Act of 2007 is low

Fewer Than Half of Clinical Trials Comply With Reporting Laws

Compliance with Food and Drug Administration Amendments Act of 2007 low, not improving
Teprotumumab is associated with better outcomes than placebo among patients with active thyroid eye disease

Teprotumumab Bests Placebo for Active Thyroid Eye Disease

Outcomes better with teprotumumab versus placebo for proptosis, inflammation, diplopia, quality of life
For women with uterine fibroids

Elagolix Cuts Heavy Menstrual Bleeding in Women With Fibroids

Significantly fewer women receiving elagolix plus add-back hormone tx versus placebo had heavy bleeding